平痫冲剂治疗小儿癫痫的研究进展

doi:10.20274/j.cnki.issn.1674-3865.2025.06.005

Abstract

Abstract:

Epilepsy, a chronic neurological disorder, has become a significant public health problem impacting children's health and development. Pingxian granules, formulated by Professor Zhang Shiqing, National Renowned TCM Physician, have gradually been proved in the effect on pediatric epilepsy, demonstrating substantial application potential and offering a novel therapeutic strategy in the treatment of pediatric epilepsy. Through sorting out the previous clinical and basic research results in the treatment of pediatric epilepsy by Pingxian granules, this paper discusses the mechanisms of action and development prospects, as well as current technical limitations, aiming to offer ideas for further exploring the therapeutic mechanism of Pingxian granules and provide reference for the prevention and treatment of pediatric epilepsy in traditional Chinese medicine.

Key words: Epilepsy, Pingxian granules, Mechanism of action, Child

CLC Number:

R742.1

Yijue JING, Zhengyu YAO, Lü GAO. Research advances in the treatment of pediatric epilepsy with Pingxian granules[J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2025, 17(6): 488-492.

References 36

[1]	Thijs RD, Surges R, O’Brien TJ, et al. Epilepsy in adults[J]. Lancet, 2019, 393(10172): 689-701.
[2]	马融, 刘振寰, 张喜莲, 等. 中医儿科临床诊疗指南·小儿癫痫(修订)[J]. 中医儿科杂志, 2017, 13(6): 1-6.
[3]	Lerche H. Drug-resistant epilepsy—time to target mechanisms[J]. Nat Rev Neurol, 2020, 16(11): 595-596.
[4]	Brodie MJ. Tolerability and safety of commonly used antiepileptic drugs in adolescents and adults: a clinician’s overview[J]. CNS Drugs, 2017, 31(2): 135-147.
[5]	孔令博, 王淑燕, 廖晓凌, 等. 中医药治疗神经内科领域临床优势病种的探讨[J]. 中国实验方剂学杂志, 2021, 27(13): 172-178.
[6]	刘冲冲, 刘金民. 癫痫的病因病机及治法概述[J]. 世界中医药, 2022, 17(19): 2818-2823.
[7]	潘利忠. 平痫冲剂对慢性癫痫大鼠脑内谷氨酸、γ-氨基丁酸含量的影响及多耐药基因表达的研究[D]. 南京: 南京中医药大学, 2010.
[8]	高旅, 刘丽娜, 史正刚, 等. 张士卿教授治疗小儿癫痫经验探析[J]. 中国中西医结合儿科学, 2020, 12(6): 473-476.
[9]	高旅, 刘驰, 吴丽萍, 等. 平痫冲剂对幼龄癫痫大鼠脑组织神经元ICAM-1、Cx43蛋白表达的影响研究[J]. 时珍国医国药, 2019, 30(5): 1060-1063.
[10]	Taylor KR, Monje M. Neuron-oligodendroglial interactions in health and malignant disease[J]. Nat Rev Neurosci, 2023, 24(12): 733-746.
[11]	高旅, 王梓安, 高蕾, 等. 从血脑屏障药物转运机制探究平痫冲剂的抗痫作用[J]. 中国中医基础医学杂志, 2024, 30(8): 1362-1366.
[12]	Zhao Y, Gan L, Ren L, et al. Factors influencing the blood-brain barrier permeability[J]. Brain Res, 2022, 1788: 147937.
[13]	Kahlhofer J, Teis D. The human LAT1-4F2hc (SLC7A5-SLC3A2) transporter complex: physiological and pathophysiological implications[J]. Basic Clin Pharmacol Toxicol, 2023, 133(5): 459-472.
[14]	Guo Y, Ashrafizadeh M, Tambuwala MM, et al. P-glycoprotein (P-gp)-driven cancer drug resistance: biological profile, non-coding RNAs, drugs and nanomodulators[J]. Drug Discov Today, 2024, 29(11): 104161.
[15]	Dudas B, Decleves X, Cisternino S, et al. ABCG2/BCRP transport mechanism revealed through kinetically excited targeted molecular dynamics simulations[J]. Comput Struct Biotechnol J, 2022, 20: 4195-4205.
[16]	Kaczmarek L. Mmp-9 inhibitors in the brain: can old bullets shoot new targets[J]? Curr Pharm Des, 2013, 19(6): 1085-1089.
[17]	Boengler K, Mantuano B, Toledano S, et al. Overexpression of Cx43: is it an effective approach for the treatment of cardiovascular diseases[J]? Biomolecules, 2025, 15(3): 370.
[18]	高旅, 刘丽娜, 史正刚, 等. 平痫冲剂对幼龄癫痫大鼠血脑屏障通透性及相关蛋白表达的影响研究[C]//第二十三次全国儿科中西医结合学术会议资料汇编. 沈阳, 2019: 167-168.
[19]	Bui TM, Wiesolek HL, Sumagin R. ICAM-1: a master regulator of cellular responses in inflammation, injury resolution, and tumorigenesis[J]. J Leukoc Biol, 2020, 108(3): 787-799.
[20]	高旅, 尚菁, 史正刚, 等. 平痫冲剂对幼龄癫痫模型大鼠血脑屏障通透性及相关蛋白Cx43、ICAM-1表达的影响[J]. 山西中医, 2021, 37(2): 53-56.
[21]	Peng S, Liu J, Liang C, et al. Aquaporin-4 in glymphatic system, and its implication for central nervous system disorders[J]. Neurobiol Dis, 2023, 179: 106035.
[22]	吴丽萍, 孙桂云, 潘利忠, 等. 平痫冲剂对戊四唑致痫大鼠乙酰胆碱和脑含水量影响的生物化学研究[J]. 卫生职业教育, 2007, 25(19): 120-121.
[23]	高旅, 尚菁, 史正刚, 等. 平痫冲剂及其拆方的抗痫作用以及对幼龄癫痫模型大鼠脑皮质基质金属蛋白酶-9、水通道蛋白-4表达的影响[J]. 中医儿科杂志, 2021, 17(3): 8-15.
[24]	田茸, 慕宝龙. 平痫冲剂对PTZ致痫大鼠中枢神经系统NMDAR1和GABA-ARα1的影响[J]. 中医儿科杂志, 2006, 2(6): 24-27.
[25]	田茸, 张士卿, 史正刚, 等. 平痫冲剂对戊四唑致痫大鼠海马氨基酸类神经递质受体的影响[J]. 中国中医药信息杂志, 2009, 16(3): 27-29.
[26]	潘利忠, 张士卿, 孙桂云. 平痫冲剂对戊四唑致痫大鼠脑组织中γ-氨基丁酸含量的影响[J]. 中华中医药学刊, 2008, 26(11): 2453-2454.
[27]	潘利忠, 张士卿, 孙桂云. 平痫冲剂对戊四唑致痫大鼠脑组织中谷氨酸含量的影响[J]. 光明中医, 2008, 23(5): 588-589.
[28]	孟陆亮, 毋荣荣, 史正刚, 等. 平痫冲剂对幼年海人酸颞叶癫痫模型大鼠学习记忆行为的影响[J]. 西部中医药, 2013, 26(4): 19-22.
[29]	唐照琦, 李彪, 王秋红, 等. 胆南星的化学成分、药理作用及相关复方临床应用的研究进展[J]. 中国药房, 2020, 31(12): 1523-1527.
[30]	柳威, 邓林华, 祁东利, 等. 天麻及其有效成分的药理作用概述[J]. 中药药理与临床, 2021, 37(4): 240-244.
[31]	李晶峰, 孙佳明, 张辉. 僵蚕的化学成分及药理活性研究[J]. 吉林中医药, 2015, 35(2): 175-177.
[32]	万新焕, 王瑜亮, 周长征, 等. 丹参化学成分及其药理作用研究进展[J]. 中草药, 2020, 51(3): 788-798.
[33]	王睿, 费洪新, 李晓明, 等. 石菖蒲的化学成分及药理作用研究进展[J]. 中华中医药学刊, 2013, 31(7): 1606-1610.
[34]	袁晓旭, 杨明明, 赵桂琴. 郁金化学成分及药理作用研究进展[J]. 承德医学院学报, 2016, 33(6): 487-489.
[35]	康莲薇, 熊南燕, 韩勤业. 代赭石的化学成分与临床应用概述[J]. 环球中医药, 2009, 2(6): 451-453.
[36]	张燕丽, 田园, 付起凤, 等. 白芍的化学成分和药理作用研究进展[J]. 中医药学报, 2021, 49(2): 104-109.

Research advances in the treatment of pediatric epilepsy with Pingxian granules

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 36

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Ruiqi CAI, Oumei HAO, Xuefeng WANG, Kexin ZHANG. Clinical observation of Xiaoji Lipi powder and anorexia plaster combined with conventional treatment for children with anorexia(spleen dysfunction syndrome) [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2025, 17(6): 461-465.
[2]	Qing WANG, Yaqin CHEN, Danfei YIN, Suli WANG, Xiaoming WANG. Exploration of prescription patterns in Professor Wang Xiaoming's treatment for pediatric food accumulation and stagnation based on data mining [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2025, 17(6): 466-471.
[3]	Qimin TANG, Yishi TU. Observation on the curative effect of Jianpi Yiqi ointment in treating anorexia(spleen and stomach qi-deficiency syndrome) in children [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2025, 17(6): 472-476.
[4]	Xuefeng WANG, Qi WANG, Minghua BAI, Ji WANG, Hua XU, Lining WANG, Baoqing ZHANG, Zhenze CUI, Zhenqi WU, Xue ZHAO, Xiuying ZHANG, Xinyue KONG, Hao HE, Xinwei LIU. Study on the assessment of "the TCM Constitution Scale for Children Aged 1⁺ to 7 Years" [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2025, 17(6): 477-487.
[5]	Ziwei WANG, Xiaolan SHU, Xi MING, Anmin WANG, Yi BI, Yi LONG, Qianyuan ZENG, Wang LI. A comprehensive study on the application progress of vitamin D in pediatric diseases [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2025, 17(6): 493-497.
[6]	Ruoyun REN, Wenqing YANG. Progress in traditional Chinese and western medicine treatments for idiopathic short stature [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2025, 17(6): 498-502.
[7]	Jinrun LUO, Shiyao ZHANG, Xuefeng WANG, Xiuying ZHANG, Xinran FENG, Yanyan NI, Zhifan TIAN. Expert investigation and research on the common syndrome types and symptoms of CAP in children [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2025, 17(6): 503-511.
[8]	Deqing NI, Jichao SUN. Traditional Chinese medicine theory of tic disorders comorbid with attention deficit hyperactivity disorder and the application [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2025, 17(6): 512-516.
[9]	Yuliang SHI, Yu PENG, Qiyan LIU, Xiaowen HONG. Experience in the diagnosis and treatment of asthmatic bronchitis in children based on the pathogenesis of "phlegm-heat coagulation and internal accumulation in the lungs" [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2025, 17(6): 517-520.
[10]	Yanqiu ZHOU, Aidong LIU, Xiaochun FENG, Xu YAN. Analyzing the experience in the treatment of children's tic disorders from the perspective of "liver collaterals" [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2025, 17(6): 521-526.
[11]	Mengdi DENG, Guiju ZHANG. Exploring the mechanism and treatment of precocious puberty combined with obesity based on the theory of "Yang transforms qi and yin takes shape" [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2025, 17(6): 527-531.
[12]	Xin FENG, Yuan SUN, Jiayu LI, Ke CHANG. Clinical experience of Professor Chang Ke in treating autism spectrum disorder in children with Xinyang decoction [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2025, 17(6): 532-536.
[13]	Huijuan SHI, Ye YUAN. Analysis of Director Jia Liujin's experience in the clever application of Cangerzi powder in compound formulations [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2025, 17(6): 537-541.
[14]	Jingjing WANG, Yaoqian LI. Experience summary of Qianzimen Pediatrics for the treatment of children's cough by using Gouteng-Jicaihua in Yangzhou [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2025, 17(6): 542-545.
[15]	Lili YANG, Yanfei YANG, Yanfen WANG, Wei JING, Danmei HU. Predictive value of neutrophil-to-albumin ratio for convulsions with mild gastroenteritis accompanied by reversible splenial lesion syndrome in children [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2025, 17(6): 546-552.